Annual Revenue
N/A
31 December 2022
Summary:
Nymox Pharmaceutical annual revenue is not available.NYMX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
31 March 2023
Summary:
Nymox Pharmaceutical quarterly revenue is not available.NYMX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
31 March 2023
Summary:
Nymox Pharmaceutical TTM revenue is not available.NYMX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
NYMX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Nymox Pharmaceutical Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$5000.00(-200.0%) | -$5000.00(-105.6%) |
| Dec 2020 | $5000.00(-95.7%) | - | - |
| Mar 2020 | - | $5000.00(-80.8%) | $90.00 K(-21.7%) |
| Dec 2019 | $116.00 K(-61.2%) | $26.00 K(-33.3%) | $115.00 K(+6.5%) |
| Sept 2019 | - | $39.00 K(+95.0%) | $108.00 K(-0.9%) |
| June 2019 | - | $20.00 K(-33.3%) | $109.00 K(-38.4%) |
| Mar 2019 | - | $30.00 K(+57.9%) | $177.00 K(-40.8%) |
| Dec 2018 | $299.00 K(+33.5%) | $19.00 K(-52.5%) | $299.00 K(-22.3%) |
| Sept 2018 | - | $40.00 K(-54.5%) | $385.00 K(+2.4%) |
| June 2018 | - | $88.00 K(-42.1%) | $376.00 K(+26.6%) |
| Mar 2018 | - | $152.00 K(+44.8%) | $297.00 K(+33.2%) |
| Dec 2017 | $224.00 K(-21.1%) | $105.00 K(+238.7%) | $223.00 K(+40.4%) |
| Sept 2017 | - | $31.00 K(+244.4%) | $158.80 K(-11.7%) |
| June 2017 | - | $9000.00(-88.5%) | $179.80 K(-43.9%) |
| Mar 2017 | - | $78.00 K(+91.2%) | $320.60 K(+12.8%) |
| Dec 2016 | $284.00 K(-89.7%) | $40.80 K(-21.5%) | $284.10 K(-10.9%) |
| Sept 2016 | - | $52.00 K(-65.3%) | $318.70 K(+1.6%) |
| June 2016 | - | $149.80 K(+261.0%) | $313.60 K(+42.8%) |
| Mar 2016 | - | $41.50 K(-45.0%) | $219.60 K(-92.0%) |
| Dec 2015 | $2.76 M(-6.4%) | $75.40 K(+60.8%) | $2.76 M(-19.1%) |
| Sept 2015 | - | $46.90 K(-15.9%) | $3.42 M(-16.8%) |
| June 2015 | - | $55.80 K(-97.8%) | $4.10 M(-14.5%) |
| Mar 2015 | - | $2.58 M(+254.4%) | $4.80 M(+62.8%) |
| Dec 2014 | $2.95 M(-12.2%) | $729.10 K(-0.9%) | $2.95 M(-6.6%) |
| Sept 2014 | - | $735.50 K(-2.2%) | $3.16 M(-0.2%) |
| June 2014 | - | $752.30 K(+2.7%) | $3.17 M(-2.7%) |
| Mar 2014 | - | $732.60 K(-21.9%) | $3.25 M(-3.2%) |
| Dec 2013 | $3.36 M(+9.3%) | $937.50 K(+26.1%) | $3.36 M(+4.6%) |
| Sept 2013 | - | $743.30 K(-11.5%) | $3.21 M(-0.7%) |
| June 2013 | - | $839.60 K(+0.1%) | $3.23 M(+1.9%) |
| Mar 2013 | - | $838.60 K(+6.2%) | $3.17 M(+3.2%) |
| Dec 2012 | $3.07 M(-1.3%) | $789.50 K(+3.3%) | $3.07 M(+0.4%) |
| Sept 2012 | - | $764.60 K(-1.8%) | $3.06 M(-1.3%) |
| June 2012 | - | $778.90 K(+5.3%) | $3.10 M(+0.4%) |
| Mar 2012 | - | $739.60 K(-4.9%) | $3.09 M(-0.8%) |
| Dec 2011 | $3.11 M(+350.3%) | $777.60 K(-3.4%) | $3.11 M(+17.5%) |
| Sept 2011 | - | $804.70 K(+5.0%) | $2.65 M(+41.6%) |
| June 2011 | - | $766.50 K(+0.2%) | $1.87 M(+54.7%) |
| Mar 2011 | - | $765.00 K(+144.3%) | $1.21 M(+74.9%) |
| Dec 2010 | $691.50 K(+66.2%) | $313.10 K(+1063.9%) | $691.50 K(+26.7%) |
| Sept 2010 | - | $26.90 K(-74.3%) | $545.90 K(-7.6%) |
| June 2010 | - | $104.60 K(-57.6%) | $590.90 K(+4.3%) |
| Mar 2010 | - | $246.90 K(+47.4%) | $566.60 K(+36.2%) |
| Dec 2009 | $416.00 K(-2.9%) | $167.50 K(+133.0%) | $415.90 K(+12.9%) |
| Sept 2009 | - | $71.90 K(-10.5%) | $368.30 K(-2.8%) |
| June 2009 | - | $80.30 K(-16.5%) | $378.80 K(-9.6%) |
| Mar 2009 | - | $96.20 K(-19.8%) | $419.10 K(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2008 | $428.40 K(-1.3%) | $119.90 K(+45.5%) | $428.40 K(-3.9%) |
| Sept 2008 | - | $82.40 K(-31.7%) | $445.80 K(+2.8%) |
| June 2008 | - | $120.60 K(+14.3%) | $433.70 K(+8.3%) |
| Mar 2008 | - | $105.50 K(-23.2%) | $400.40 K(-7.6%) |
| Dec 2007 | $433.90 K(-2.0%) | $137.30 K(+95.3%) | $433.50 K(+13.9%) |
| Sept 2007 | - | $70.30 K(-19.5%) | $380.50 K(-15.9%) |
| June 2007 | - | $87.30 K(-37.0%) | $452.20 K(-6.8%) |
| Mar 2007 | - | $138.60 K(+64.4%) | $485.40 K(+9.6%) |
| Dec 2006 | $442.90 K(+3.9%) | $84.30 K(-40.6%) | $443.00 K(-4.9%) |
| Sept 2006 | - | $142.00 K(+17.8%) | $465.60 K(+9.7%) |
| June 2006 | - | $120.50 K(+25.3%) | $424.30 K(+0.8%) |
| Mar 2006 | - | $96.20 K(-10.0%) | $421.10 K(-1.3%) |
| Dec 2005 | $426.30 K(+32.4%) | $106.90 K(+6.2%) | $426.80 K(+7.1%) |
| Sept 2005 | - | $100.70 K(-14.2%) | $398.50 K(-0.4%) |
| June 2005 | - | $117.30 K(+15.1%) | $400.00 K(+9.3%) |
| Mar 2005 | - | $101.90 K(+29.6%) | $365.80 K(+13.5%) |
| Dec 2004 | $321.90 K(+60.9%) | $78.60 K(-23.1%) | $322.20 K(+16.8%) |
| Sept 2004 | - | $102.20 K(+23.0%) | $275.80 K(+18.9%) |
| June 2004 | - | $83.10 K(+42.5%) | $231.90 K(+3.2%) |
| Mar 2004 | - | $58.30 K(+81.1%) | $224.70 K(+12.1%) |
| Dec 2003 | $200.10 K(-44.7%) | $32.20 K(-44.8%) | $200.50 K(-8.5%) |
| Sept 2003 | - | $58.30 K(-23.2%) | $219.10 K(-5.8%) |
| June 2003 | - | $75.90 K(+122.6%) | $232.60 K(-29.4%) |
| Mar 2003 | - | $34.10 K(-32.9%) | $329.50 K(-7.9%) |
| Dec 2002 | $361.70 K(+53.7%) | $50.80 K(-29.2%) | $357.60 K(+177.0%) |
| Sept 2002 | - | $71.80 K(-58.4%) | $129.10 K(-46.4%) |
| June 2002 | - | $172.80 K(+177.8%) | $240.80 K(+5.1%) |
| Mar 2002 | - | $62.20 K(-135.0%) | $229.20 K(-2.5%) |
| Dec 2001 | $235.30 K(+49.2%) | -$177.70 K(-196.8%) | $235.10 K(-47.4%) |
| Sept 2001 | - | $183.50 K(+13.8%) | $446.90 K(+42.6%) |
| June 2001 | - | $161.20 K(+136.7%) | $313.50 K(+67.2%) |
| Mar 2001 | - | $68.10 K(+99.7%) | $187.50 K(+17.4%) |
| Dec 2000 | $157.70 K(+2.9%) | $34.10 K(-31.9%) | $159.70 K(-10.7%) |
| Sept 2000 | - | $50.10 K(+42.3%) | $178.90 K(-21.8%) |
| June 2000 | - | $35.20 K(-12.7%) | $228.70 K(-21.9%) |
| Mar 2000 | - | $40.30 K(-24.4%) | $293.00 K(-6.0%) |
| Dec 1999 | $153.30 K(-44.0%) | $53.30 K(-46.6%) | $311.80 K(-27.8%) |
| Sept 1999 | - | $99.90 K(+0.4%) | $431.80 K(-0.1%) |
| June 1999 | - | $99.50 K(+68.4%) | $432.10 K(-0.1%) |
| Mar 1999 | - | $59.10 K(-65.9%) | $432.70 K(-8.6%) |
| Dec 1998 | $273.60 K(+1509.4%) | $173.30 K(+73.0%) | $473.50 K(+118.0%) |
| Sept 1998 | - | $100.20 K(+0.1%) | $217.20 K(+0.1%) |
| June 1998 | - | $100.10 K(+0.2%) | $217.00 K(+0.0%) |
| Mar 1998 | - | $99.90 K(-220.4%) | $216.90 K(-0.2%) |
| Dec 1997 | $17.00 K | -$83.00 K(-183.0%) | $217.30 K(-27.6%) |
| Sept 1997 | - | $100.00 K(0.0%) | $300.30 K(+49.9%) |
| June 1997 | - | $100.00 K(-0.3%) | $200.30 K(+99.7%) |
| Mar 1997 | - | $100.30 K | $100.30 K |
FAQ
- What is the all time high annual revenue for Nymox Pharmaceutical?
- What is the all time high quarterly revenue for Nymox Pharmaceutical?
- What is the all time high TTM revenue for Nymox Pharmaceutical?
What is the all time high annual revenue for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual revenue is $3.36 M
What is the all time high quarterly revenue for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly revenue is $2.58 M
What is the all time high TTM revenue for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high TTM revenue is $4.80 M